Q1 FY27 Results: Revenue up 12%, net profit down 29% at Rs. 144.70 lakh

Pat NegativeEbitda Margin CompressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.0%Reaction day

₹62.25

prior close

₹62.40

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+0.7% vs market

Commodity Chemicals peers, median of 54sector-0.6%+1.6% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 1.6 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

+0.0

15m

+0.0

30m

-2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.0+0.4+0.7-0.6+1.6

Next day

+0.7+0.5+0.2-0.9+1.6

+1.0+0.6+0.4-0.5+1.5

+3.5+0.7+2.8-1.5+5.0

+3.6+1.1+2.5-2.1+5.7

+1.6+0.5+1.1-2.6+4.2

+1.0+1.3-0.2-2.2+3.3

15d

+4.4+0.5+3.9-1.8+6.2

+9.9-0.8+10.7-0.8+10.7

+1.2-0.9+2.1-0.5+1.7

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Archit Organosys reported Q1 FY27 revenue from operations of Rs. 3,708.24 lakh, up 11.7% from Rs. 3,319.56 lakh in Q1 FY26. However, net profit fell 28.9% to Rs. 144.70 lakh from Rs. 203.59 lakh. Total income rose to Rs. 3,768.67 lakh. EPS stood at Rs. 0.71 versus Rs. 0.99. No exceptional items were reported. Auditor G. K. Choksi and Co. issued an unqualified limited review report.

Likely market impact

Higher topline but sharp fall in profit signals margin pressure; may weigh on near-term sentiment despite revenue growth.